CYP19A1 and endometrioid stromal sarcoma: Hormone therapy is an effective treatment option for patients with advanced or recurrent endometrial stromal sarcoma, including progesterone, Gonadotropin-Releasing Hormone agonist, aromatase inhibitors, and so on.